{"id":46921,"date":"2022-08-04T09:02:04","date_gmt":"2022-08-04T07:02:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/"},"modified":"2022-08-04T09:02:04","modified_gmt":"2022-08-04T07:02:04","slug":"aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/","title":{"rendered":"AIBODY Partners with German Heart Centre Berlin to Revolutionize Diagnosis and Treatment of Congenital Heart Disease"},"content":{"rendered":"
\n

LONDON–(BUSINESS WIRE)–AIBODY<\/a>, the world\u2019s first Physiology-as-a-Service platform, announced today that it has signed a collaboration agreement with the German Heart Centre Berlin (DHZB)<\/a>, a leading medical research institute specializing in cardiovascular disease. This agreement focuses on the development of a suite of innovative solutions that will facilitate the diagnosis and treatment of congenital heart disease.\n<\/p>\n

<\/a><\/p>\n

\nThe collaboration will utilize AIBODY\u2019s digital human physiology engine to create a lifelike, highly detailed 3D and 4D model of a beating human heart, capable of replicating the broad range of cardiovascular pathologies found in patients with congenital heart defects. Informed by clinical data shared by the DHZB cardiology team, the model will become a dynamic learning resource for practicing and trainee clinicians worldwide, including cardiologists, pediatricians and radiologists, expanding their working knowledge of congenital heart defects and helping them more effectively recognize such conditions in actual patients.\n<\/p>\n

\nOnce the educational resource is complete, AIBODY will proceed to develop AI tools that will automatically extract features from cardiac sonograms to create an anatomically accurate, \u201cdigitally twinned\u201d 3D and 4D model of a patient\u2019s heart, providing a diagnostic aid to doctors and radiologists to help optimize personalized diagnosis and treatment for each patient.\n<\/p>\n

\n\u201cWe will begin by creating a comprehensive catalogue of conditions to provide a \u2018living\u2019 reference guide for doctors and radiologists to help recognize and define what they are seeing on patient imagery,\u201d said Richard Littlehales, CEO of AIBODY. \u201cOur ultimate goal is to build an AI-driven diagnostic device based on creating a \u2018digital twin\u2019 of each individual patient\u2019s heart, reflecting their actual physiology and giving the clinical teams a better understanding of that patient\u2019s specific condition and its likely development over time.\u201d\n<\/p>\n

\n\u201cBy combining our clinical knowledge and experience with the cutting-edge simulation technology AIBODY is bringing to the table, we will enhance our capacity to diagnose and treat patients, leading to better outcomes for patients around the world,\u201d said Prof. Stanislav Ovroutski, senior consultant of the DHZB Clinic for Congenital Heart Defects and Pediatric Cardiology. \u201cOur first product will be a dynamic clinical reference guide that doctors will be able to access on their phones or tablets. We expect to have that ready within a year.\u201d\n<\/p>\n

\nAbout AIBODY<\/b>\n<\/p>\n

\nAIBODY is a cloud-based Physiology-as-a-Service platform that offers real-time, immersive medical simulations using the world\u2019s first digital human organism. AIBODY\u2019s unique approach produces highly detailed, lifelike physiological responses to virtually any simulated medical condition or treatment protocol, recreating interrelated biophysical, physiological, and biochemical processes occurring within a human body. AIBODY has been spun off from AUG Global<\/a>, the international technology group, and raised a seed funding round from leading global venture capital firms. For further information, please visit www.aibody.io<\/a>.\n<\/p>\n

\nAbout German Heart Centre Berlin<\/b>\n<\/p>\n

\nThe German Heart Centre Berlin (Deutsches Herzzentrum Berlin) is an internationally renowned high-performance hospital and medical research center specializing in the treatment of cardiovascular and thoracic diseases, implantation of mechanical circulatory support systems, and heart and lung transplantation. For further information, please visit www.dhzb.de<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor media inquiries:
\n
Anna Wallace
\n
awallace@first-intl.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LONDON–(BUSINESS WIRE)–AIBODY, the world\u2019s first Physiology-as-a-Service platform, announced today that it has signed a collaboration agreement with the German Heart Centre Berlin (DHZB), a leading medical research institute specializing in cardiovascular disease. This agreement focuses on the development of a suite of innovative solutions that will facilitate the diagnosis and treatment of congenital heart disease. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46921","6":"format-standard","7":"category-industry"},"yoast_head":"\nAIBODY Partners with German Heart Centre Berlin to Revolutionize Diagnosis and Treatment of Congenital Heart Disease - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AIBODY Partners with German Heart Centre Berlin to Revolutionize Diagnosis and Treatment of Congenital Heart Disease - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LONDON–(BUSINESS WIRE)–AIBODY, the world\u2019s first Physiology-as-a-Service platform, announced today that it has signed a collaboration agreement with the German Heart Centre Berlin (DHZB), a leading medical research institute specializing in cardiovascular disease. This agreement focuses on the development of a suite of innovative solutions that will facilitate the diagnosis and treatment of congenital heart disease. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-04T07:02:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220804005020\/en\/1532159\/21\/AI_Body_logo-color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"AIBODY Partners with German Heart Centre Berlin to Revolutionize Diagnosis and Treatment of Congenital Heart Disease\",\"datePublished\":\"2022-08-04T07:02:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\\\/\"},\"wordCount\":532,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005020\\\/en\\\/1532159\\\/21\\\/AI_Body_logo-color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\\\/\",\"name\":\"AIBODY Partners with German Heart Centre Berlin to Revolutionize Diagnosis and Treatment of Congenital Heart Disease - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005020\\\/en\\\/1532159\\\/21\\\/AI_Body_logo-color.jpg\",\"datePublished\":\"2022-08-04T07:02:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005020\\\/en\\\/1532159\\\/21\\\/AI_Body_logo-color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220804005020\\\/en\\\/1532159\\\/21\\\/AI_Body_logo-color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AIBODY Partners with German Heart Centre Berlin to Revolutionize Diagnosis and Treatment of Congenital Heart Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AIBODY Partners with German Heart Centre Berlin to Revolutionize Diagnosis and Treatment of Congenital Heart Disease - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/","og_locale":"en_US","og_type":"article","og_title":"AIBODY Partners with German Heart Centre Berlin to Revolutionize Diagnosis and Treatment of Congenital Heart Disease - Pharma Trend","og_description":"LONDON–(BUSINESS WIRE)–AIBODY, the world\u2019s first Physiology-as-a-Service platform, announced today that it has signed a collaboration agreement with the German Heart Centre Berlin (DHZB), a leading medical research institute specializing in cardiovascular disease. This agreement focuses on the development of a suite of innovative solutions that will facilitate the diagnosis and treatment of congenital heart disease. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-04T07:02:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220804005020\/en\/1532159\/21\/AI_Body_logo-color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"AIBODY Partners with German Heart Centre Berlin to Revolutionize Diagnosis and Treatment of Congenital Heart Disease","datePublished":"2022-08-04T07:02:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/"},"wordCount":532,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220804005020\/en\/1532159\/21\/AI_Body_logo-color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/","url":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/","name":"AIBODY Partners with German Heart Centre Berlin to Revolutionize Diagnosis and Treatment of Congenital Heart Disease - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220804005020\/en\/1532159\/21\/AI_Body_logo-color.jpg","datePublished":"2022-08-04T07:02:04+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220804005020\/en\/1532159\/21\/AI_Body_logo-color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220804005020\/en\/1532159\/21\/AI_Body_logo-color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/aibody-partners-with-german-heart-centre-berlin-to-revolutionize-diagnosis-and-treatment-of-congenital-heart-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"AIBODY Partners with German Heart Centre Berlin to Revolutionize Diagnosis and Treatment of Congenital Heart Disease"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46921","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46921"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46921\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46921"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46921"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46921"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}